Mirimus is an award-winning New York biotech company that propels the scientific research behind medical breakthroughs. The company addresses human health issues on a global scale by pioneering ways to diagnose and treat diseases, and by creating animal and cell models for cutting-edge medical research. Founded in 2010 by Cold Spring Harbor Laboratory scientists Prem Premsrirut, MD, PhD, Scott Lowe, PhD, Gregory Hannon, PhD, Stephen Elledge, PhD, and Christof Fellmann, PhD, Mirimus has partnered with leading institutions around the world, allowing it to deepen its understanding of molecular diagnostics, genetic engineering, and therapeutics.
